SV Life Sciences Managers LLP, Manager of Dementia Discovery Fund (DDF) Appoints World …

SV Life Sciences Managers LLP, Manager of Dementia Discovery Fund (DDF) Appoints World-Renowned Chief Scientific Officer to Lead the New DDF Investment Team Dementia Discovery FundPosted on: 25 Jan 16 The Dementia Discovery Fund (DDF) www.TheDDFund.com, an innovative global investment fund launched in October 2015 to discover and develop new disease modifying drugs for dementia, announces the appointment of Tetsuyuki Maruyama PhD as its Chief Scientific Officer. Dr Tetsuyuki Maruyama will join the DDF in April 2016 from Takeda Pharmaceutical Co. Ltd where for the past five years he has been Senior VP, General Manager, Pharmaceutical Research Division, leading global drug discovery after his initial appointment as Head of CNS Research. Prior to this he was Director of GlaxoSmithKline Plc’s neuroscience research centre in Singapore, and led Alzheimer’s Disease target…


Link to Full Article: SV Life Sciences Managers LLP, Manager of Dementia Discovery Fund (DDF) Appoints World …